Binhui Biopharmaceutical Co., Ltd.
Binhui Biopharmaceutical Co., Ltd.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-02-04 | NCT07382531 | |
| OH2 Injection in Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 3 | 2025-07-25 | NCT05868707 | |
| OH2 Injection in Combination With HX008 for Melanoma. | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-07-24 | NCT04616443 | |
| OH2 Administered by Intratumoral Injection | Solid Tumor | Not yet recruiting | Phase 1 | 2024-12-27 | NCT05954091 | |
| OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer | Advanced Liver Cancer | Recruiting | Phase 1 | 2024-12-20 | NCT05698459 | |
| OH2 Oncolytic Viral Therapy in Solid Tumors | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-12-20 | NCT03866525 |